Literature DB >> 3302085

Lipoprotein metabolism in diabetes mellitus.

B V Howard.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3302085

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


× No keyword cloud information.
  81 in total

Review 1.  Regulation of the synthesis, processing and translocation of lipoprotein lipase.

Authors:  J E Braun; D L Severson
Journal:  Biochem J       Date:  1992-10-15       Impact factor: 3.857

2.  Association of plasma triglyceride and C-peptide with coronary heart disease in Japanese-American men with a high prevalence of glucose intolerance.

Authors:  R W Bergstrom; D L Leonetti; L L Newell-Morris; W P Shuman; P W Wahl; W Y Fujimoto
Journal:  Diabetologia       Date:  1990-08       Impact factor: 10.122

3.  The distribution profiles of very low density and low density lipoproteins in poorly-controlled male, type 2 (non-insulin-dependent) diabetic patients.

Authors:  R W James; D Pometta
Journal:  Diabetologia       Date:  1991-04       Impact factor: 10.122

Review 4.  [Value of biguanide in therapy of diabetes mellitus].

Authors:  E Haupt; U Panten
Journal:  Med Klin (Munich)       Date:  1997-08-15

5.  Glucagon, cyclic AMP and adrenaline stimulate the degradation of low-density lipoprotein by cultured rat hepatocytes.

Authors:  N F Brown; A M Salter; R Fears; D N Brindley
Journal:  Biochem J       Date:  1989-09-01       Impact factor: 3.857

Review 6.  The effect of dietary intervention on serum lipid levels in type 2 diabetes mellitus.

Authors:  Nilo B Cater; Abhimanyu Garg
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

7.  Increased cholesterylester transfer activity in complicated type 1 (insulin-dependent) diabetes mellitus--its relationship with serum lipids.

Authors:  R P Dullaart; J E Groener; L D Dikkeschei; D W Erkelens; H Doorenbos
Journal:  Diabetologia       Date:  1989-01       Impact factor: 10.122

8.  Ragaglitazar: a novel PPAR alpha PPAR gamma agonist with potent lipid-lowering and insulin-sensitizing efficacy in animal models.

Authors:  Ranjan Chakrabarti; Reeba K Vikramadithyan; Parimal Misra; Jagadheshan Hiriyan; Suryaprakash Raichur; Ravi K Damarla; Cynthia Gershome; Juluri Suresh; Ramanujam Rajagopalan
Journal:  Br J Pharmacol       Date:  2003-09-01       Impact factor: 8.739

9.  The effect of low density lipoprotein composition on the regulation of cellular cholesterol synthesis: a comparison in diabetic and non-diabetic subjects.

Authors:  D Owens; S McBrinn; P Collins; A Johnson; G H Tomkin
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

10.  Glomerular structural and functional changes in a high-fat diet mouse model of early-stage Type 2 diabetes.

Authors:  P Wei; P H Lane; J T Lane; B J Padanilam; S C Sansom
Journal:  Diabetologia       Date:  2004-08-27       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.